1 – 15 of 29
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
2023) In Virchows Archiv(
- Contribution to journal › Article
-
Mark
Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
(
- Contribution to journal › Article
- 2022
-
Mark
Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
(
- Contribution to journal › Article
- 2021
-
Mark
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response
(
- Contribution to journal › Article
-
Mark
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
(
- Contribution to journal › Article
-
Mark
Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
The prognostic impact of the tumour stroma fraction : A machine learning-based analysis in 16 human solid tumour types
(
- Contribution to journal › Article
- 2020
-
Mark
Diagnostic value of insulinoma-associated protein 1 (INSM1) and comparison with established neuroendocrine markers in pulmonary cancers
(
- Contribution to journal › Article
-
Mark
Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases
(
- Contribution to journal › Article
-
Mark
Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC
(
- Contribution to journal › Article
-
Mark
Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11
(
- Contribution to journal › Article